Vortrag
Esketamine nasal spray for rapid reduction of depressive symptoms in adult patients with major depressive disorder at imminent risk for suicide: results from the phase 3 programme
Speaker
Datum:
26.11.2020 ,
Zeit:
14:30
|
Topic: Wissenschaftliches Programm
Details